Literature DB >> 29843139

HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer.

Ertao Zhai1, Wei Liang2, Yi Lin2,3, Linlin Huang2, Xin He4, Shirong Cai1, Jianhui Chen1, Ning Zhang2, Jiali Li5, Qiuyang Zhang6, Yulong He1, Zhirong Zeng2, Minhu Chen2, Lixia Xu2, Sui Peng2.   

Abstract

BACKGROUND/AIMS: HSP70/HSP90-organizing protein (HOP) is an adaptor protein that mediates heat shock protein 70 (HSP70) and HSP90 folding. HOP can be secreted by cancer cells and promote malignant cell growth in an autocrine manner. Here, we studied its role in gastric cancer (GC).
METHODS: HOP mRNA and protein levels were detected by quantitative real-time PCR and western blotting, respectively, and enzyme-linked immunosorbent assay was used to determine the serum levels. Immunohistochemistry was performed to analyze HOP expression in 117 GC tissues and 32 adjacent normal tissues. The Cell Counting Kit-8 cell viability assay, flow cytometry, and western blotting were used to analyze the effects of HOP on cell proliferation and apoptosis, and the potential underlying mechanisms.
RESULTS: HOP mRNA and protein levels were significantly higher in GC tissues than in normal tissues in our medical center (P< 0.001) and in The Cancer Genome Atlas database (P< 0.001). GC patients had higher serum levels of HOP than age-matched healthy controls (P< 0.001); however, once tumors were removed, serum levels significantly decreased (P< 0.01). In human GC tissues, increased HOP expression was associated with tumor progression and poor survival. Notably, autocrine HOP promoted cell proliferation through the phospholipase Cγ1-extracellular signal-regulated kinase 1/2-dependent pathway, and inhibited cell apoptosis by regulating the activities of caspase 9, caspase 3, and B-cell lymphoma 2. Blocking extracellular HOP with neutralizing antibody reduced proliferation and enhanced fluorouracil-induced apoptosis of GC cells.
CONCLUSIONS: Our findings demonstrate that HOP is an important molecular marker and prognostic factor for GC, and functionally contributes to tumor cell growth and survival. These results provide a rationale for considering HOP as a potential therapeutic target and chemosensitizer in GC.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Apoptosis; Autocrine; Gastric Cancer; Hop; Proliferation

Mesh:

Substances:

Year:  2018        PMID: 29843139     DOI: 10.1159/000490080

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

1.  Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.

Authors:  Weigang Dai; Jinning Ye; Zhimei Zhang; Liang Yang; Hui Ren; Hui Wu; Jianhui Chen; Jieyi Ma; Ertao Zhai; Shirong Cai; Yulong He
Journal:  Diagn Pathol       Date:  2018-10-17       Impact factor: 2.644

2.  The Prognostic Significance of Hsp70 in Patients with Colorectal Cancer Patients: A PRISMA-Compliant Meta-Analysis.

Authors:  Guangyu Gao; Songtao Liu; Zhen Yao; Yanyan Zhan; Wenyue Chen; Yulong Liu
Journal:  Biomed Res Int       Date:  2021-04-16       Impact factor: 3.411

3.  Clinicopathological significance of HSP70 expression in gastric cancer: a systematic review and meta-analysis.

Authors:  Xiaolu Wang; Li Xie; Lijing Zhu
Journal:  BMC Gastroenterol       Date:  2021-11-22       Impact factor: 3.067

Review 4.  With or without You: Co-Chaperones Mediate Health and Disease by Modifying Chaperone Function and Protein Triage.

Authors:  Selin Altinok; Rebekah Sanchez-Hodge; Mariah Stewart; Kaitlan Smith; Jonathan C Schisler
Journal:  Cells       Date:  2021-11-11       Impact factor: 7.666

Review 5.  The Hsp70-Hsp90 go-between Hop/Stip1/Sti1 is a proteostatic switch and may be a drug target in cancer and neurodegeneration.

Authors:  Kaushik Bhattacharya; Didier Picard
Journal:  Cell Mol Life Sci       Date:  2021-10-22       Impact factor: 9.261

Review 6.  The Role of the Heat-Shock Proteins in Esophagogastric Cancer.

Authors:  Francisco Tustumi; Gabriel Andrade Agareno; Ricardo Purchio Galletti; Rafael Benjamim Rosa da Silva; Julia Grams Quintas; Lucas de Abreu Sesconetto; Daniel José Szor; Nelson Wolosker
Journal:  Cells       Date:  2022-08-27       Impact factor: 7.666

7.  Expression of SLC17A9 in hepatocellular carcinoma and its clinical significance.

Authors:  Jingdong Wu; Yongfei Yang; Jiansheng Song
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.